HomeLink Healthcare partners with The London Clinic to deliver The London Clinic at Home service

In a step forward for patient-centred cancer care, The London Clinic has partnered with HomeLink Healthcare to deliver The London Clinic at Home, a new pre-chemotherapy bloods service for patients in their own homes.

By combining HomeLink’s expertise in at-home clinical services with The London Clinic’s renowned cancer care, this initiative reimagines what it means to receive treatment—making healthcare more personal and efficient. It also allows The London Clinic to streamline treatment pathways, making the chemotherapy experience more efficient and less stressful for patients.

The new partnership means that eligible patients receiving chemotherapy at The London Clinic can now have essential pre-treatment blood tests in the comfort and privacy of their own home, delivered by HomeLink’s team of highly skilled nurses and healthcare professionals.

This innovative service reduces the need for patients to travel into hospital prior to treatment — a welcome change for those who may be feeling unwell, fatigued, or immunocompromised due to cancer or ongoing treatment.

Benefits of the service include:

• Comfort and convenience: Patients can remain in familiar surroundings, reducing anxiety and physical strain associated with travel and hospital visits.
• Additional capacity: An extension of existing services, offering patients the choice to be treated in the community.
• Efficient clinical decision-making: Rapid turnaround of blood results ensures timely adjustments to treatment plans, minimising delays and supporting optimal outcomes.
• Personalised support: The partnership ensures even more choice for patients, with care plans tailored to their unique needs and circumstances outside of hospital.

Voices from the Partnership

The London Clinic, one of the UK’s most prestigious independent hospitals, shares HomeLink Healthcare’s commitment to innovation and excellence in care. This collaboration reflects both organisations’ dedication to delivering high-quality  healthcare that adapts to patients’ needs. Leaders from both organisations have emphasised the transformative potential of this initiative.

Jill Ireland, CEO and Clinical Director of HomeLink Healthcare commented: “We are proud to partner with The London Clinic to offer a service that enables patients to receive part of their treatment pathway at home. By delivering safe and reliable pre-chemotherapy blood testing at home, we are offering choice, whilst maintaining the high clinical standards that both of our organisations uphold.”

A representative from The London Clinic echoed these sentiments: “Our patients deserve care that is as compassionate as it is clinically excellent. This partnership further allows us to bring our values to life—ensuring that every patient feels supported, respected, and cared for, every step of the way.”

Conclusion

The challenge of cancer care is not only medical, but also deeply human. By joining forces, HomeLink Healthcare and The London Clinic are sending a powerful message: that healthcare should be built around patients’ lives, offering support where and when it’s needed most. The introduction of home-based pre-chemotherapy blood testing is a vital step towards a future where care is compassionate, connected, and truly patient-centred.

The service is already receiving positive feedback from patients and clinicians alike, and there are plans to explore further in-home services as part of an expanding partnership.